From the clinical trial working experience with Xyrem in narcolepsy/cataplexy individuals at therapeutic doses, two people noted panic and just one reported sleeplessness pursuing abrupt discontinuation with the termination of your medical demo; in the two people with stress, the frequency of cataplexy experienced greater markedly at the same time.